Tigecycline (Tygacil)

DRUG4 trials

Sponsors

Pfizer, Ain Shams University, Mohamed Sabry

Conditions

Central Nervous System InfectionsComplicated Intra-abdominal InfectionsComplicated Skin and Skin Structure InfectionsIdentify the Predictors of Antibiotic ResistanceIntra-Abdominal InfectionsSkin Disease, Infectious

Unknown Phase

Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)

CompletedNCT00683332

PfizerComplicated Intra-abdominal Infections, Complicated Skin and Skin Structure Infections

Start: 2007-04-30End: 2010-05-31Updated: 2011-07-08

Tygacil Drug Use Investigation

CompletedNCT01789905

PfizerIntra-Abdominal Infections, Skin Disease, Infectious

Start: 2013-04-15End: 2017-06-16Updated: 2019-02-06

Comparing Tigecycline Vs. Colistimethate in CNS Infections

Not yet recruitingNCT06702943

Ain Shams UniversityCentral Nervous System Infections

Start: 2024-12-01End: 2027-06-30Target: 70Updated: 2024-11-25

Predictors of Antimicrobial Resistance in the Respiratory Intensive Care Unit of Alexandria Main University Hospital

CompletedNCT06750744

Mohamed SabryIdentify the Predictors of Antibiotic Resistance

Start: 2024-10-01End: 2024-12-12Updated: 2024-12-27